TickerFacts.

Quince Therapeutics, Inc. (IRLA): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2026-05-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

55.73M
As of 2025-12-31
1.02M
As of 2026-06-30
+15.5%
3-year compound annual growth
+13.5%
5-year compound annual growth
2018-12-31: 3.41M2019-12-31: 26.87M2020-12-31: 29.54M2021-12-31: 30.07M2022-12-31: 36.14M2023-12-31: 42.97M2024-12-31: 44.00M2025-12-31: 55.73M55.73M
2018-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3155.73M+26.6%2026-04-10, Balance as of period end
2024-12-3144.00M+2.4%2026-04-10, Balance as of period end
2023-12-3142.97M+18.9%2025-03-24, Balance as of period end
2022-12-3136.14M+20.2%2024-04-01, Balance as of period end
2021-12-3130.07M+1.8%2023-03-15, Balance as of period end
2020-12-3129.54M+10.0%2022-03-01, Balance as of period end
2019-12-3126.87M+687.4%2021-03-01, Balance as of period end
2018-12-313.41Mn/a2020-03-16, Balance as of period end